During the past decade, Center for Oncology and Blood Disorders conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Oncology and Blood Disorders" #1 collaborator was "Atridia Pty Ltd." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Center for Oncology and Blood Disorders" are "Breast Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Advanced Solid Tumor" (1 trials), "Advanced Solid Tumors" (1 trials) and "Bile Duct Cancer" (1 trials). Many other conditions were trialed in "Center for Oncology and Blood Disorders" in a lesser frequency.

Most popular intervention types in "Center for Oncology and Blood Disorders" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (1 trials), "INT230-6" (1 trials), "NUV-868" (1 trials), "Olaparib" (1 trials) and "SHR-A1811" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Oncology and Blood Disorders" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Center for Oncology and Blood Disorders". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Center for Oncology and Blood Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Oncology and Blood Disorders, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".